Inventor · Melbourne, AU

Alistair George Draffan

15Patents
3h-index
26Co-inventors
56Inventor score

Filing activity: Dec 24, 2004 → Oct 20, 2015

Most-cited inventions

PatentTitleAreaCited byStatus
US8119607B2 Bicyclic nucleosides and nucleotides as therapeutic agents Human Necessities 89 Active
US8802840B2 Bicyclic nucleosides and nucleotides as therapeutic agents Chemistry; Metallurgy 43 Active
US8501699B2 Bicyclic nucleosides and nucleotides as therapeutic agents Human Necessities 18 Active
US8598193B2 Polycyclic agents for the treatment of respiratory syncytial virus infections Chemistry; Metallurgy 3 Active
US9120775B2 Viral polymerase inhibitors Chemistry; Metallurgy 2 Active
US8546389B2 Viral polymerase inhibitors Chemistry; Metallurgy 2 Active
US8785478B2 Viral polymerase inhibitors Chemistry; Metallurgy 2 Active
US9675694B2 Polycyclic agents for the treatment of respiratory syncytial virus infections Chemistry; Metallurgy 1 Active
US9365554B2 Viral polymerase inhibitors Chemistry; Metallurgy 0 Active
US9163029B2 Substituted imidazo[1,2-a]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections Chemistry; Metallurgy 0 Active
US9540387B2 Substituted imidazo[1,2-d]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections Chemistry; Metallurgy 0 Active
US9447080B2 Viral polymerase inhibitors Chemistry; Metallurgy 0 Active
US8598194B2 Polycyclic agents for the treatment of respiratory syncytial virus infections Chemistry; Metallurgy 0 Active
US8796303B2 Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections Human Necessities 0 Active
US8604034B2 Substituted imidazo[1,2-α]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus (RSV) infections Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.